Showing 15,401 - 15,420 results of 15,661 for search '(( six ((teer decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.96s Refine Results
  1. 15401

    Table_1_Multiparametric MRI enables for differentiation of different degrees of malignancy in two murine models of breast cancer.docx by Mirjam Gerwing (7365833)

    Published 2022
    “…A decreasing accumulation of gadolinium during tumor progression was also visible in both models in LA-ICP-MS. …”
  2. 15402

    Table_1_Pooled human bone marrow-derived mesenchymal stromal cells with defined trophic factors cargo promote dermal wound healing in diabetic rats by improved vascularization and... by Hélène Willer (13271226)

    Published 2022
    “…Our novel clinical-scale manufacturing concept is comprised of six single donor hMSCs master cell banks that are pooled to a working cell bank from which an extrapolated number of 70,000 clinical doses of 1x10<sup>6</sup> hMSCs/cm<sup>2</sup> wound size can be manufactured within only three passages. …”
  3. 15403

    Image_3_Pooled human bone marrow-derived mesenchymal stromal cells with defined trophic factors cargo promote dermal wound healing in diabetic rats by improved vascularization and... by Hélène Willer (13271226)

    Published 2022
    “…Our novel clinical-scale manufacturing concept is comprised of six single donor hMSCs master cell banks that are pooled to a working cell bank from which an extrapolated number of 70,000 clinical doses of 1x10<sup>6</sup> hMSCs/cm<sup>2</sup> wound size can be manufactured within only three passages. …”
  4. 15404

    Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on <i>Mycobacterium tuberculosis</i>-Specific CD4<sup>+</sup> T-Cells by Kapil K. Saharia (3160167)

    Published 2016
    “…</p><p>Conclusion</p><p>TB treatment alters the functional profile of Mtb-specific CD4 T-cells reflecting shifts towards a less differentiated maturational profile and decreases PD-1 and CTLA-4 expression. …”
  5. 15405

    Table_2_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.DOCX by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  6. 15406

    Image_4_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  7. 15407

    Image_7_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  8. 15408

    Table_3_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.DOCX by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  9. 15409

    Image_5_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  10. 15410

    Table_4_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.DOCX by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  11. 15411

    Image_6_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  12. 15412

    Image_2_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  13. 15413

    Image_8_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  14. 15414

    Image_3_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  15. 15415

    Image_9_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…While the majority of CPHN cells express (in overall compartments of pancreas) the pan-endocrine transcription factor NKX2.2 and beta-cell specific NKX6.1 in comparable frequency in fetal and infant/child cases (81.9 ± 6.3 vs. 82.8 ± 3.8% NKX6.1<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.9; 88.0 ± 4.7 vs. 82.1 ± 5.3% NKX2.2<sup>+</sup>-CPHN cells of total CPHN cells, fetal vs. infant/child, p = 0.4), the frequency of clustered CPHN cells expressing NKX6.1 or NKX2.2 is lower in infant/child vs. fetal cases (1.2 ± 0.3 vs. 16.7 ± 4.7 clustered NKX6.1<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01; 2.7 ± 1.0 vs. 16.0 ± 4.0 clustered NKX2.2<sup>+</sup>-CPHN cells/mm<sup>2</sup>, infant/child vs. fetal, p < 0.01).…”
  16. 15416

    Yorku.Grassland&OpenDisturbedArea.Oct03-2016 by Pedro Carreira (3124434)

    Published 2016
    “…Increased Canopy cover will lead to a decrease in vegetative cover. </p><p> </p><p>2. …”
  17. 15417

    Data_Sheet_1_The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis.docx by Biqian Fu (6181871)

    Published 2019
    “…<p>Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. …”
  18. 15418

    Pathogenic <i>NLGN1</i> variants exhibit abnormal sub-localization and expression. by Moe Nakanishi (4392145)

    Published 2017
    “…<p>(A) Fluorescence images of COS7 cells transfected WT or mutant NLGN1 with HA-tag. …”
  19. 15419

    Data Sheet 1_An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis.docx by Xiaolu Yang (285041)

    Published 2025
    “…</p>Conclusions<p>ASCL1 exerts oncogenic effects in BC and represents a potential therapeutic target for intervention.…”
  20. 15420

    Data_Sheet_1_Daytime, Not Nighttime, Elevated Atmospheric Carbon Dioxide Exposure Improves Plant Growth and Leaf Quality of Mulberry (Morus alba L.) Seedlings.docx by Songmei Shi (10095466)

    Published 2021
    “…The present study was to determine the impact of daytime and/or nighttime eCO<sub>2</sub> on growth and quality of mulberry (Morus alba L.), a perennial multipurpose cash plant. Six-month-old mulberry seedlings were hence grown in environmentally auto-controlled growth chambers under four CO<sub>2</sub> concentrations: (1) ambient CO<sub>2</sub> (ACO<sub>2</sub>, 410 μmol mol<sup>–1</sup> daytime/460 μmol mol<sup>–1</sup> nighttime), (2) sole daytime elevated CO<sub>2</sub> (DeCO<sub>2</sub>, 710 μmol mol<sup>–1</sup>/460 μmol mol<sup>–1</sup>), (3) sole nighttime elevated CO<sub>2</sub> (NeCO<sub>2</sub>, 410 μmol mol<sup>–1</sup>/760 μmol mol<sup>–1</sup>), and (4) continuous daytime and nighttime elevated CO<sub>2</sub> (D + NeCO<sub>2</sub>, 710 μmol mol<sup>–1</sup>/760 μmol mol<sup>–1</sup>). …”